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Objectives: The present study investigated the potential adverse effects of multi-wall carbon nanotubes (MWCNTs) on pregnant dams and
embryonic development following maternal exposure in rats. 
Methods: MWCNTs were orally administered to pregnant rats from gestational day (GD) 6 through 19 at dose levels of 0, 8, 40, 200, and
1000 mg/kg/day. During the test period, clinical signs, mortality, body weights, food consumption, serum biochemistry, oxidant-antioxidant
status, gross findings, organ weights, and Caesarean section findings were examined. 
Results: All animals survived to the end of the study. A decrease in thymus weight was observed in the highest dose group. However,
maternal body weight, food consumption, serum biochemical parameters, and oxidant-antioxidant balance in the kidneys were not affected
by treatment with MWCNTs. No treatment-related differences in gestational index, embryo-fetal mortality, or fetal and placental weights
were observed between treated and control groups. 
Conclusions: The results show that 14-day repeated oral dosing of MWCNTs during pregnancy induces minimal maternal toxicity at 1000
mg/kg/day in rats. Under these experimental conditions, the no-observed-adverse-effect level of MWCNTs is considered to be 200
mg/kg/day for dams and 1000 mg/kg/day for embryonic development.
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INTRODUCTION
Carbon nanotubes (CNTs) have a structure that looks like a
graphite sheet rolled into a cylinder-like shape with a nano-size
diameter. Single-wall CNTs are 1-2 nm in diameter with a length
of 15   m or less. Multi-wall carbon nanotubes (MWCNTs)
consist of a multi-layered carbon cylinder and have an increased
diameter of 10-30   m. CNTs show distinctive electronic,
thermal, and mechanical characteristics according to their
structures and sizes. These systems are being widely used in
electronic engineering, computers, aerospace, architecture,
etc. [1]. However, despite their useful characteristics, because
they may have potential adverse effects on humans and the
environment, their use has been limited until their safety is
guaranteed [2,3]. In order for nanomaterials to be widely used
as consumer products, they must be thoroughly investigated
to assess potential toxicities using animal models.
CNTs are reported to produce toxic reactions in cells and
whole animal experiments. As such, they are presumed to be
harmful to human health in the event of exposure to CNTs;
however, at this time there is insufficient toxicity
information available to verify or dispute this assumption
[2]. Humans can be exposed to these potentially toxic
substances through inhalation, skin contact, feeding, or as an
occupational hazard at high concentrations [1]. It has been
suggested that inhaled CNTs and other nanoparticles are
likely to evade phagocytosis, penetrate lung tissue, and
translocate to other organs causing systemic cell toxicity and
injury [4]. Inhaled CNTs, while being removed from
respiratory organs and entering the gastrointestinal system
through mucociliary synergism, could be transmitted
through dirty hands unconsciously or through polluted water
and food. Recently it was reported that absorption of CNTs
following oral exposure led to oxidative damage of DNA
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Open Accesswhich occurred in a dose-dependent manner affecting liver
and lung cells [5]. It has also been determined that CNTs can
enter primary or cultured human skin cells, inducing the
release of pro-inflammatory cytokines, leading to oxidative
damage and decreased cell viability [6]. 
Recently, Zhu et al. [7] confirmed increased DNA damage
and DNA mutation in stomach stem cells of mice exposed to
MWCNTs, and Pacurari et al. [8] proved that CNTs induce
oxidative damages and activate various routes of DNA
damage. Karlsson et al. [9] reported that MWCNTs cause
serious DNA damage to A549 type II epithelial cell, and
Additionally, intraperitoneally administered MWCNT
induced mesothelioma in p53(+/-) heterozygote mice [10].
These results strongly suggest that oxidative stress and DNA
damage induced by CNTs might be involved in genotoxicity
and carcinogenicity. Many substances that cause oxidative
stress and effect DNA cause extreme toxicity in pregnant
dams and on embryonic development [11,12], but to date
there have been no reports on the potential harmful effects of
CNTs on pregnant dams and embryonic development. 
This study was intended to determine the safety of
nanomaterials that may be hazardous to the human body and
the environment due to their increased production and use.
Since MWCNTs are widely produced in our country we
selected this material to evaluate its potential harmful effects
on pregnant dams and embryonic development in rats.
MATERIALS AND METHODS
I. Experiment Animals and Rearing Conditions
Male and nulliparous female Sprague-Dawley rats 10
weeks of age were obtained from a specific-pathogen free
colony at Orient Bio (Seoul, Korea) and placed on study
following one week of quarantine and acclimatization. For
mating, two females were placed into a cage with a male rat
overnight. Successful mating was confirmed by the presence
of sperm in the vaginal smear, and the following 24 hours
was designated as day 0 of gestation (GD 0). The mated
females were housed individually in polycarbonate cages,
and were provided sterilized tap water and fed commercial
rodent chow (Samyang Feed, Wonju, Korea) ad libitum.
This experiment was conducted following approval of the
Chonnam University Animal Experiment Ethics Committee
and was performed in accordance with current regulations
for animal experiments.
II. Experiment Substance and Medication
MWCNTs (CM-95, 10-15 nm in diameter, ~20   m in
length) were purchased from Hanhwa Nanotech (Incheon,
Korea). These MWCNTs have also been designated as an
alternative reference material for the sponsorship program for
the safety testing of nanomaterials by the Organization for
Economic Co-operation and Development (OECD)  Working
Party on Manufactured Nanomaterials (WPMN). The purity of
MWCNTs is 95%, and they consist of 95% carbon and 5% iron
[13]. Based on other reports [10], the test article was suspended
in a 1% sodium carboxymethylcellulose (CMC) vehicle. The
suspension was subjected to ultrasonication for 3 minutes to
obtain a more homogenous and dispersed suspension. The test
mixture was prepared daily prior to use, and the 1% CMC
solution alone was used as the vehicle control. The test mixture
was administered by gavage to pregnant rats from GD 6
through 19 at a dose volume of 20 mL/kg/day. Control rats
received an equivalent volume of vehicle alone.
III. Experimental Group Composition and Dosage 
According to a previous study [14], no toxic effect was
found at a dose of 2500 mg/kg in a single oral dose toxicity
study. However, in the case of a single intraperitoneal
injection, the median lethal dose was 600 mg/kg, and with
12-day repeated intraperitoneal injections, changes in body
weight, feed intake, organ weight, and kidney, spleen, lymph
node, thymus, and liver histological changes were observed
at 60 mg/kg/day. Slight nephropathy was observed even at
6 mg/kg/day. Based on these results, we orally administered
1000, 100, and 10 mg/kg/day to five females per group for
10 days. Maternal toxicity and developmental toxicity was
not observed even in the high-dose group. Therefore, we
established the highest dose as 1000 mg/kg/day, which is
the limit test dose recommended by OECD test guidelines.
Using the common ratio of 5, we added high, medium, and
low dose groups of 200, 40, and 8 mg/kg/day, respectively,
along with a vehicle control group. A total of 12 confirmed
mated females were evaluated per group.
IV. Clinical Signs, Body Weight, and Food Consumption
During the experiment, all pregnant females were
examined daily for mortality, morbidity, general appearance,
and behavior. Maternal body weights were measured on
GDs 0, 6, 9, 12, 15, and 20, and individual food consump-
tion was determined on GDs 0, 6, 9, 12, 15, and 19. 
V. Gross Findings and Organ Weights
All pregnant females were euthanized and exsanguinated
via the aorta on GD 20. A complete gross postmortem
examination was performed. The absolute and relative
weights of the lungs, adrenal glands, liver, spleen, kidneys,
thymus, heart, and ovaries were recorded.
VI. Serum Biochemical Examination
Blood samples were drawn from the posterior vena cava using
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rpm for 10 minutes within 1 hour of collection. Using a
biochemical automatic analysis device (Dir-chem 4000i,
Fujifilm Co., Japan), we measured the concentration of aspartate
aminotransferase, alanine aminotransferase, total cholesterol,
triglyceride, alkaline phosphatase, blood urea nitrogen,
creatinine, glucose, total bilirubin, total protein, and albumin. 
VII. Caesarean Section
The ovaries and uterus of each female were removed and
examined for the number of corpora lutea and the status of
all implantation sites, i.e. live and dead fetuses, early and late
resorptions, and total implantations were recorded.
Resorption was classified as ‘early’ only when a resorption
site resembling a dark brown blood clot with no embryonic
tissue was visible, and ‘late’ when both placental and
embryonic tissues were visible upon postmortem
examination.
VIII. Analysis of Kidney Oxidation Damage
We analyzed the extent of lipid peroxidation and oxidative
damage on kidney tissue which is suggested to be the main
target organ of carbon nanomaterials. After crushing the
kidney tissue using a glass-teflon homogenous grinder for a
few seconds, the smashed tissue was centrifuged at 4  C, at
800 g for 10 minutes. The protein was quantified according
to the method of Lowry et al. [15]. Activity of antioxidant
enzymes, glutathione concentration, and degree of lipid
peroxidation were also evaluated.
A) Measurement of catalase activity
Catalase was measured in accordance with Aebi’s method
[16]. After putting 1.0 mL of 30 mM hydrogen peroxide
(H2O2) solution into a 2.0 mL sample diluted with 50 mM
phosphate buffer solution (pH 7.0), light absorbance change
was measured at a wavelength of 240 nm at 20  C. The
activity of catalase was measured by calculating the amount
of enzyme that decomposed 1   M of H2O2 in 1 minute and
that value was indicated as 1 unit.
B) Measurement of glutathione reductase (GR) activity
Zymogen 200   L was added to 2.5 mL of 0.1 M
phosphate buffer (pH 7.6, 0.5 mM EDTA included), 150   L
of 1 mM glutathione disulfide (GSSG), and 150   L of 0.1
mM nicotinamide adenine dinucleotide phosphate
(NADPH). The solution was mixed and maintained at 25  C
for 2 minutes then the decrease of light absorbance was
measured [17]. One unit was defined as the amount of
enzyme which oxidized 1 M of NADPH in 1 minute.
C) Measurement of glutathione peroxidase (GPx) activity
The methods of Paglia and Valentine were used to
measure GPx [18]. GPx, in the presence of cumene
hydroxide, catalyzes oxidation of glutathione, and in the
presence of GR and NADPH, is changed to a reduced form.
At the same time, NADPH is oxidized to NADP+. The
decrease of light absorbance was measured at 340 nm.
D) Measurement of glutathione-S-transferase (GST)
activity
GST activity was measured in accordance with the
method of Habig et al. [19]. For reaction assistance, 1 mL of
2.5 mM 1-chloro-2,4-dinitrobenzene, 0.5 mL of 1 mM
glutathione, and 0.1 M phosphate buffer (pH 6.5) were
added. The reaction solution was maintained at 25  C for 5
minutes, zymogen was added, and change of light
absorbance was measured at 340 nm for 2 minutes. One unit
was defined as the amount of enzyme that crystallized
production of 1 mol of 1-chloro-2,4-dinitrobenzene. 
E) Measurement of glutathione (GSH) concentration
Measurement of glutathione concentration was analyzed
by the method of Moron et al. [20]. The tissue was mixed
with 5   M EDTA, 0.6 mM of 5,5-dithiol-bis(2-nitrobenzoic
acid), 0.2 M NADPH, and 0.1 M sodium phosphate buffer
(pH 7.5) which contained GR. After cultivating at room
temperature for 2 minutes, light absorbance was measured at
412 nm using a standard curve known to represent GSH
concentration.
F) Measurement of lipid peroxidation content
A thiobarbituric acid (TBA) reaction method was used for
lipid peroxidation analysis [21]. The tissue was mixed with
0.375% TBA reagent and 15% trichloroacetic acid within
0.25-N hydrochloric acid. The reaction mixture was
maintained in boiling water for 30 minutes, and then
centrifuged for 5 minutes with 1811 g. The light absorbance of
the supernatant was measured as 535 nm. Malondialdehyde
(MDA), a product of lipid peroxidation, was calculated
using the extinction coefficient 1.56 10
5/M cm, and the
result shown as MDA   M/mg protein. 
IX.  Statistical Method
Data are presented as means SD. The unit of statistical
measurement is the pregnant female or the litter. GraphPad
InStat version 3.0 (GraphPad Software Inc., CA, USA) was
used for statistical analysis of control and treatment groups.
Statistical significance was examined at 5% and 1%. 
RESULTS
During the study period, no abnormal findings were
observed in the dams of the control, 8 mg/kg, and 200
mg/kg groups. On the other hand, decreased locomotor
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mg/kg group, and 3 dams of the 1000 mg/kg group (data not
shown). 
Upon measuring the weight of dams (Table 1) to evaluate
treatment-related body weight changes, no statistically
significant differences were observed between control and
treatment animals. In addition, there were no statistically
significant differences in maternal weight gain during
pregnancy, gravid uterine weight, and corrected body
weights between the groups.
Upon measuring the change in food consumption (data not
shown), there was a significant increase on GD 19 in the 40
mg/kg group compared to the control group, but food
consumption in the other groups and on other days was
similar to that of the control group. 
No gross findings were observed in dams of any group
upon evaluation on GD 20. 
At necropsy (Table 2), there were significant decreases in
absolute and relative weights of the thymus in the 1000
mg/kg group, while other organ weights in the treatment
groups did not show significant difference compared to the
control group.
To judge functional abnormalities in the dams, we
analyzed serum biochemical values on GD 20 (Table 3).
There were no statistically significant differences in the
concentrations of aspartate aminotransferase, alanine
aminotransferase, total cholesterol, triglyceride, alkaline
phosphatase, blood urea nitrogen, creatinine, glucose, total
bilirubin, total protein, or albumin between the control and
treatment groups. As shown in Table 4, there were also no
significant differences observed in catalase, GR, GST, GSH,
and MDA levels in the treatment groups compared with
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Table 1.Body weight changes of pregnant rats
Parameters
Multi-wall carbon nanotubes (mg/kg/day)
0 8 40 200 1000
No. of rats mated
No. of pregnant rats
GD 0
GD 6
GD 9
GD12
GD15
GD20
Body weight gain during pregnancy
Corrected body weight
b
Gravid uterine weight
12
11
246.5   11.14
a
283.7   12.60
296.2   15.63
309.8   15.56
323.0   16.30
381.3   25.97
134.8   17.12
319.9   16.77
061.4   16.72
12
09
247.5   11.90
284.6   15.97
293.5   16.38
309.2   13.97
324.2   12.88
386.6   13.88
139.1   14.79
317.3   16.92
069.3   9.49
12
10
247.1   17.08
286.1   19.65
297.3   20.35
312.5   20.66
328.6   21.05
387.4   28.61
140.3   21.11
323.4   23.07
063.9   21.99
12
12
243.7   16.96
280.4   16.70
289.4   18.08
303.2   19.52
318.6   20.59
367.2   28.13
123.6   23.42
306.3   28.76
060.9   20.35
12
11
242.0   19.65
283.4   25.12
290.6   27.92
303.9   28.66
320.3   31.07
377.4   39.56
135.4   26.26
303.4   39.51
074.0   9.79
GD: gestational day.
aValues are presented as means  SD (g), 
bBody weight on GD20 - gravid uterine weight.
Table 2.Absolute and relative organ weights of pregnant rats
Parameters
Multi-wall carbon nanotubes (mg/kg/day)
0 8 40 200 1000
No. of dams
Body weight at term
Lung (g)
Per body weight (%)
Adrenal glands (g)
Per body weight (%)
Liver (g)
Per body weight (%)
Spleen (g)
Per body weight (%)
Kidneys (g)
Per body weight (%)
Thymus (g)
Per body weight (%)
Heart (g)
Per body weight (%)
Ovaries (g)
Per body weight (%)
11
381.3   25.97
a
01.25   0.122
00.33   0.029
0.087   0.0078
0.023   0.0017
15.39   1.673
04.03   0.245
00.71   0.101
00.19   0.032
02.15   0.185
00.56   0.050
00.49   0.063
00.13   0.021
01.11   0.105
00.29   0.022
0.146   0.0205
0.038   0.0061
9
386.6   13.88
01.30   0.153
00.34   0.040
0.079   0.0137
0.020   0.0037
15.45   0.862
04.00   0.161
00.66   0.114
00.17   0.028
02.12   0.178
00.55   0.044
00.50   0.060
00.13   0.015
01.16   0.096
00.30   0.022
0.140   0.0170
0.036   0.0040
10
387.4   28.61
01.24   0.083
00.32   0.021
0.076   0.0127
0.020   0.0028
15.50   1.661
04.00   0.260
00.64   0.058
00.17   0.015
02.15   0.216
00.56   0.048
00.51   0.081
00.13   0.021
01.10   0.081
00.28   0.021
0.149   0.0145
0.039   0.0049
12
367.2   28.13
01.24   0.106
00.34   0.035
0.089   0.0142
0.024   0.0048
15.08   1.964
04.10   0.337
00.62   0.084
00.17   0.020
02.09   0.232
00.57   0.045
00.44   0.107
00.12   0.022
01.15   0.151
00.31   0.035
0.147   0.0334
0.040   0.0099
11
377.4   39.56
01.20   0.090
00.32   0.021
0.087   0.0143
0.023   0.0056
15.05   1.855
03.98   0.208
00.63   0.068
00.17   0.013
01.98   0.207
00.53   0.042
00.36   0.101*
00.10   0.022*
01.08   0.119
00.29   0.024
0.127   0.0125
0.034   0.0056
aValues are presented as means SD (g). 
* Significant difference at p<0.05  compared to the control group.those of the control group.
Table 5 summarizes the reproductive and litter findings for
the pregnant rats treated with MWCNTs on GDs 6 through 19.
The overall pregnancy rate was 83.3-100%, results were similar
between each experimental group, and no totally resorbed litters
were found in any group. There were no significant differences
between the control and treatment groups related to the number
of corpora lutea, implantations, pre- and post-implantation loss
rates, fetal deaths, litter size, gender ratio of live fetuses, fetal
body weights, or placental weights. 
DISCUSSION
Physicochemical characteristics of nanomaterials originate
from their small size, chemical composition, surface
structure, solubility, shape, and condensation. As a result of
their unique physicochemical and electrical characteristics,
MWCNT usability has greatly increased in various industry
sectors, and production is gradually increasing throughout
the world [1]. Despite their excellent physicochemical
Maternal Toxicity of Multi-Wall Carbon Nanotubes
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Table 4.Antioxidant enzymes, glutathione, and lipid peroxidation in the kidneys of pregnant rats
Parameters
Multi-wall carbon nanotubes (mg/kg/day)
0 8 40 200 1000
No. of dams
Catalase (unit/mg protein)
Glutathione reductase (unit/mg protein)
Glutathione-S-transferase (  mol/mg protein)
Glutathione peroxidase (nmol/mg protein)
Glutathione (nmol/mg protein)
Malondialdehyde (  mol/mg protein)
11
026.5   3.87
a
199.3   10.43
006.8   0.63
002.6   0.48
264.2   28.74
064.6   11.12
9
023.0   4.03
206.6   34.61
006.1   0.54
002.5   0.12
298.8   15.86
070.8   15.86
10
025.5   4.49
231.3   16.89
006.0   0.68
002.6   0.35
315.8   63.2
71.4   26.66
12
027.6   5.11
251.5   15.90
006.3   0.24
002.4   0.31
230.8   68.03
072.7   12.25
11
022.8   6.34
228.9   44.63
005.7   0.41
002.6   0.51
375.1   29.78
072.4   10.24
aValues are presented as means SD.
Table 5.Caesarean section data of pregnant rats
Parameters
Multi-wall carbon nanotubes (mg/kg/day)
0 8 40 200 1000
No. of dams
No. of corpora lutea
No. of implantation sites
Pre-implantation loss (%)
b
Fetal deaths
Post-implantation loss (%)
c
Litter size
Sex ratio (male/female)
Fetal weight (g): Male
Female
Placental weight (g)
11
14.7   3.26
a
11.6   3.70
20.0   20.49
00.5   0.82
03.1   5.65
11.2   3.34
1.32
3.62   0.194
3.39   0.233
0.53   0.050
9
15.1   2.76
12.9   2.47
14.2   11.36
00.4   0.88
03.3   6.67
12.4   2.51
0.96
3.63   0.199
3.40   0.236
0.51   0.059
10
14.6   1.84
11.9   4.18
18.7   25.95
00.5   0.53
03.6   3.81
11.4   3.92
1.07
3.65   0.219
3.50   0.287
0.58   0.081
12
13.8   2.12
11.5   3.63
19.1   24.97
00.4   0.67
04.7   6.30
11.1   3.70
1.22
3.42   0.150
3.28   0.150
0.53   0.057
11
14.8   1.40
14.0   1.61
05.5   7.02
00.5   0.52
03.2   3.67
13.5   1.51
1.10
3.61   0.181
3.41   0.204
0.51   0.047
aValues are presented as means SD.
bPre-implantation loss (%) = [(No. of corpora lutea - No. of implantation sites)/ No. of corpora lutea]  100.
cPost-implantation loss (%) = [(No. of implantation sites - No. of live embryos)/ No. of implantation sites]  100.
Table 3.Serum biochemical values of pregnant rats
Parameters
Multi-wall carbon nanotubes (mg/kg/day)
0 8 40 200 1000
No. of dams
Aspartate aminotransferase (IU/L)
Alanine aminotransferase (IU/L)
Total cholesterol (mg/dL)
Triglyceride (mg/dL)
Blood urea nitrogen (mg/dL)
Alkaline phosphatase (IU/L)
Creatinine (mg/dL)
Glucose (mg/dL)
Total bilirubin (mg/dL)
Albumin (g/dL)
Total protein (g/dL)
11
073.9   16.86
a
038.2   3.97
105.1   18.68
285.7   109.48
020.1   3.68
923.6   377.02
000.4   0.05
087.6   24.59
000.6   0.08
003.5   0.38
005.7   0.48
9
072.8   12.69
036.8   4.20
098.3   18.21
326.7   108.40
018.7   2.66
915.3   368.65
000.3   0.04
089.3   20.68
000.5   0.04
003.1   0.02
005.3   0.33
10
066.9   10.33
037.6   5.65
094.6   18.97
348.4   107.86
019.6   2.70
903.7   3.90
000.4   0.05
088.6   23.20
000.5   0.31
003.3   0.12
005.3   0.26
12
059.9   19.62
035.3   6.73
092.3   18.87
308.8   108.53
018.0   3.26
892.2   374.21
000.3   0.05
094.6   19.26
000.6   0.33
003.2   0.67
005.3   0.87
11
061.8   11.28
035.4   5.03
095.0   18.02
360.1   109.73
017.4   2.60
921.7   334.31
000.3   0.04
089.0   25.61
000.5   0.07
003.2   0.024
005.3   0.34
aValues are presented as means SD.characteristics, the unique features of nanomaterials have
aroused concern regarding the effects they may have on
humans and the environment. As the interest in the potential
adverse effects of nanomaterials increases, scientists
continue to evaluate their risks to human health and the
environment [3]. According to previous studies, nano-
materials readily travel throughout the body, deposit in target
organs, penetrate cell membranes, lodge in mitochondria,
and may induce adverse biological effects at cellular,
subcellular, and protein levels [2,4]. Therefore, it is thought
that the use of nanomaterials should be limited due to
possible negative effects on humans and the environment,
and confirming their safety through various toxicity
experiments should be a top priority [2]. 
The present study was conducted to investigate potential
adverse effects of MWCNTs on pregnant dams and
embryonic development in rats orally dosed 0, 8, 40, 200,
and 1000 mg/kg/day from GDs 6 through 19. Oxidative
damage is not typically measured during standard embryo-
fetal development studies in our laboratory [22]; however,
we conducted an additional experiment based on the fact that
oxidative stress is thought to play an important role in the
manifestation of maternal and embryotoxicity which may be
associated with MWCNTs [11]. The results obtained in this
study showed that 14-day oral repeated dosing of MWCNTs
during pregnancy is minimally maternotoxic, and not
embryotoxic in rats.
Results related to CNTs reported by many researchers
[3,23] have shown more or less discord in the extent of
toxicity manifested in the lungs and other organs [24].
Specifically, it has been reported that CNTs can be harmful
to mammalian cells, human T cells [25], HEK293 kidney
epithelial cells [26], dermal fibroblast cells [27], and skin
epithelial cells [28] in time- and dose-dependent manners.
However, it has also been reported that MWCNTs did not
induce cytotoxicity or chromosomal aberration in Chinese
hamster fibroblast V79 cells [29]. In addition, Di Sotto et al.
[30] reported that MWCNTs did not have any mutagenic
effects based on reverse mutation tests using germs.
When Wistar rats were exposed to MWCNTs through
nasal inhalation for 13 weeks with dosages of 0.4 mg/m
3 or
more, increases in lung weights, lung lymph nodes,
polymorphonuclear neutrophils, harmful collagen of
bronchoalveolar cell detergent, and histopathologic changes
of the airway occurred. Liang et al. [31] also observed
suppressed body weights and increased weights of liver,
spleen, and lungs following repeated intraperitoneal
injections of MWCNTs at 250 mg/kg for 28 days. Muller et
al. [23] reported that after having administered a single
tracheal instillation of MWCNTs to rats, inflammatory and
fibrotic reactions occurred in the lungs, and the degree of
lesions found was dose-dependent. On the contrary, it has
been reported that non-purified CNTs did not induce
significant signs of lung toxicity 4 weeks after intratracheal
administration in guinea pigs [32]. Mitchell et al. [33]
reported that even when mice were exposed to MWCNTs
through systematic inhalation at a concentration of 0.3-5
mg/m
3 for 7 or 14 days, immune function alteration was
observed without lung inflammation or tissue damage. Li et
al. [34] reported that intratracheal instillation of 0.05 mg of
MWCNTs resulted in inflammation of bronchi and severe
destruction of alveolar structures, but inhalation exposure of
MWCNTs at 32.61 mg/m
3 did not cause these pulmonary
lesions. Thus, it is considered that differences in lung lesions
induced by intratracheal instillation and inhalation of CNTs
are caused by the size and distribution of the condensed
matter within the lungs. The present study showed that
repeated oral administration of MWCNTs caused a decrease
in thymus weight in pregnant rats at 1000 mg/kg, but did not
cause any harmful effects on embryonic development. The
reason why these results do not correspond to results of other
researches is considered to be related to factors such as time
of exposure, concentration, duration, and physicochemical
characteristics of the CNTs used. The difference in
absorbance according to route of administration is
considered the main cause of the result discrepancies. The
results of this study and the existing literature suggest that
CNTs do not exert clear and remarkable effects in
experimental animals, and products using CNTs are
relatively safe for consumer use.
The decreased locomotor activity and depression observed
in the 40 mg/kg and 1000 mg/kg groups occurred at a low
frequency. These findings are often observed even in normal
rats, and as such it is judged that these findings were
spontaneous and not related to the MWCNT treatment.
Corresponding to the fact that MWCNTs did not have any
adverse effects related to clinical findings in pregnant rats,
no treatment-related effects were observed in body weight
change and weight gain of dams. An increase in food
consumption was temporarily observed in the 40 mg/kg
group, but this was determined to be an accidental finding
unrelated to MWCNT treatment since it did not correspond
with body weight change. In addition, according to necropsy
results, serum biochemical numerical values, and oxidative
damage assessment of the kidneys, no treatment-related
effects were found in any group tested. However, the
significant decreases in thymus absolute and relative weights
observed in the highest dose group were considered to be
related to the MWCNT treatment since the decrement was
remarkable (about 27 and 23%, respectively) compared to
the control group and showed a clear-cut dose-response
relationship. Recently, Mitchell et al. [33] reported that mice
exposed to inhalation over the whole body at a concentration
of 0.3-5 mg/m
3 MWCNTs for 7 or 14 days had immune
function alterations including T cell antibody-dependent
reactions, T cell proliferation, and a decrease of natural killer
function, without lung inflammation or tissue damage.
Bottini et al. [25] also proved that MWCNTs significantly
Environmental Health and Toxicology 2011; 26: e2011006
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manner through programmed cell death in human T cells.
Our research and collected results suggest that
administration of MWCNTs in experiment animals could
have harmful effects on systemic immune functions and
thymus weight, and strongly suggest that the thymus, which
is one of the immune organs, is one of the major target
tissues of MWCNTs. The exact cause of the decrease in
thymus weight was not determined; therefore, it is suggested
that additional research be conducted to clarify the
mechanism through which CNTs affect the thymus. 
CONCLUSION
Fourteen-day repeated oral doses of MWCNTs during
pregnancy induce minimal maternal toxicity (i.e., decreased
thymus weight) and no embryotoxicity at 1000 mg/kg/day in
rats. Under these experimental conditions, the no-observed-
adverse-effect level of MWCNTs is considered to be 200
mg/kg/day for pregnant rats, and 1000 mg/kg/day or more
for embryonic development. This research is expected to
assist in determining the risks of MWCNTs to humans by
providing reproductive and developmental toxicity
information based on repeated oral exposure of rats during
pregnancy.
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